General Dermatology

Fall Clinical 2025 continues its tradition of blending cutting-edge science with practical insights for the modern dermatologist.

New evidence supports biologic agents as precise, better-tolerated alternatives to systemic immunosuppressants for life-threatening dermatologic emergencies.

This October, discover how dermatology and oncology collaborate to enhance breast cancer care and support patients through innovative therapies and teamwork.

Explore the intricate link between dermatology and psychiatric disorders, revealing how mental health impacts skin conditions and treatment approaches.

Azitra reveals promising preclinical results for ATR-01, a novel treatment targeting ichthyosis vulgaris, paving the way for future clinical trials.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the approval of cemiplimab as adjuvant immunotherapy for high-risk CSCC, FDA safety communication on RF microneedling, dermatologists' role in breast cancer awareness, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore essential insights on breast cancer diagnosis and dermatology, highlighting key practices for early detection and patient care.

Explore the critical role of dermatologists in managing cutaneous toxicities from breast cancer therapies, enhancing patient quality of life and treatment outcomes.

Researchers found that while 96% of respondents use social media daily, most dermatologic information encountered online remains inaccurate or non-evidence-based.

Topical dapsone shows promise in treating various mucocutaneous diseases, including rosacea and neutrophilic dermatoses, with a favorable safety profile.

Yale researchers uncover how skin stem cells enhance healing during embryonic development, paving the way for advanced skin grafts and regenerative medicine.

Dermatologists play a vital role in identifying breast cancer symptoms, bridging gaps in care for conditions like Paget disease and inflammatory breast cancer.

If passed, the Safe Step Act could reduce treatment delays by prohibiting step therapy for FDA-labeled, guideline-supported agents.

Dermatologists enhance breast cancer care by managing skin issues, identifying genetic risks, and improving patient quality of life during treatment.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about roflumilast's expanded access for children as young as 2, LP-10 for oral lichen planus, SYX-5219's IND clearance, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Selective JAK1 inhibition with upadacitinib may offer a fast-acting, steroid-sparing option for refractory lichen amyloidosis by interrupting IL-31–mediated itch and the itch–scratch cycle.

Dermatologists play a crucial role in breast cancer care, enhancing patient outcomes through early detection and innovative research on keratin-targeting therapies.

Explore the vital role of dermatology in breast cancer care, from early detection to managing skin issues related to treatment and radiation.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the FDA approvals of guselkumab for pediatric plaque psoriasis and PsA, along with remibrutinib for CSU, LEO Pharma's acquisition of spesolimab for GPP, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.